GLP-1s, Weight Loss & Rising Drug Spend: How Employers Can Adapt
By Beckie Fenrick, PharmD, MBA; Emily Crisano, PharmD, RPh; and Jason Peterson, RPh The market for GLP-1 receptor agonists is […]
The Power of Independent PBM Rebate Reconciliation
By Bethany Hruschak, Senior Manager, Pricing and Analytics Managing pharmacy costs is an essential but complex task for organizations striving
Pricing Guarantee Reconciliation
Navion conducted an independent rebate and discount reconciliation for a 3,400-life group, uncovering $660,000 in rebates and discounts value initially missed by the PBM’s own reconciliation process.
Navigating the Changing Landscape of Pharmacy Rebates: What Self-Funded Employers Need to Know
By Beckie Fenrick, PharmD, MBA Navigating the evolving rebate landscape requires in-depth expertise, especially as regulatory changes and PBM strategies
The Biosimilar Shift: How New Options for Stelara and Humira are Reshaping Specialty Care for Payers
The biosimilar landscape is continuing to rapidly evolve, and 2025 marks a pivotal year for payers seeking cost-saving opportunities. With Stelara biosimilars making their debut and Humira biosimilars continuing to gain traction, plan sponsors will have more options than ever to control costs while ensuring members have access to the essential therapies they need.
AlignRx Consulting Rebrands as Navion, Continues to Elevate Pharmacy Benefits Solutions to New Heights
AlignRx Consulting, a leader in the pharmacy benefit consulting space, is rebranding as Navion, reflecting the company’s evolution in delivering industry-leading pharmacy benefit solutions.
Cost-Containment Client Success
A year after implementing the solution, the group has saved $425,000 between pharmacy and medical Rx costs with minimal member disruption.
